III.6 Tamoxifen-induced changes of the uterus: MRI features

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Van Hoe, L ^a   Gryspeerdt, S ^a   Bloemen, H ^a   Timmerman, D ^a   Neven, P ^b   Marchal, G ^a   Vergote, I ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b Hospital St Jan   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTRAST ENHANCEMENT; ENDOMETRIUM CANCER; FEMALE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYP; PRIORITY JOURNAL; UTERUS CANCER;

EID: 0031690212     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00104-X     Document Type: Conference Paper

References (3)

1. Ascher SM, Johnson JC, Barnes WA, Bae CJ, Patt RH, Zeman RK. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology 1996, 200, 105-110.
2. Gryspeerdt S, Van Hoe L, Timmerman D, Marchal G, Baert AL, Vergote I. Specific uterine changes in patients undergoing tamoxifen treatment: MR imaging. Eur Radiol 1997, 7, 198.
3. Gryspeerdt S, Van Hoe L, Bosmans H, Baert AL, Vergote I, Marchai G. T2-weighted MR imaging of the uterus: comparison of optimized fast spin echo and HASTE sequences with conventional fast spin echo. Am J Roeht (in press).